In-Q-Tel

“Sensible Biotechnologies: It also secured up to $20 million in non-dilutive funding from the Government of Slovakia and the European Union. $27M Series A including In-Q-Tel.”

“$255.5M Series B at $2.5B valuation with an investor roster including In-Q-Tel. Develops autonomous AI agents to probe enterprise systems and simulate real-world cyber attacks”